Literature DB >> 412789

Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients.

R U Sorensen, R C Stern, S H Polmar.   

Abstract

Lymphocyte responses to the mitogens phytohemagglutinin and concanavalin A and to Streptococcus pyogenes, Staphylococcus aureus, Haemophilus influenzae, and Pseudomonas aeruginosa were evaluated in patients with cystic fibrosis and in normal individuals. Lymphocyte proliferation in vitro was stimulated by gentamicin-killed whole bacteria, and the proliferative response was measured by [3H]thymidine incorporation. The in vitro lymphocyte responses to antibiotic-killed bacterial reached maximum thymidine incorporation after 5 days in culture and followed a unimodal dose-response curve for each of the bacteria studied. A significant specific incapacity to respond to P. aeruginosa was detected in cystic fibrosis patients with advanced clinical disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412789      PMCID: PMC421296          DOI: 10.1128/iai.18.3.735-740.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  IgM-mediated, T cell-independent suppression of humoral immunity.

Authors:  J Ordal; S Smith; D Ness; R K Gershon; F C Grumet
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

2.  A 5 YEAR CLINICAL EVALUATION OF A THERAPEUTIC PROGRAM FOR PATIENTS WITH CYSTIC FIBROSIS.

Authors:  C F DOERSHUK; L W MATTHEWS; A S TUCKER; H NUDLEMAN; G EDDY; M WISE; S SPECTOR
Journal:  J Pediatr       Date:  1964-11       Impact factor: 4.406

3.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

4.  The IgA system. 3. IgA levels in the serum and saliva of pediatric patients--evidence for a local immunological system.

Authors:  M A South; W J Warwick; F A Wolheim; R A Good
Journal:  J Pediatr       Date:  1967-11       Impact factor: 4.406

Review 5.  The cellular recognition in vitro of antigens related to human histocompatibility.

Authors:  V P Eijsvoogel
Journal:  Semin Hematol       Date:  1974-07       Impact factor: 3.851

Review 6.  Selective immunosuppression using antigens and antibodies as pharmacologic agents.

Authors:  G W Siskind
Journal:  Fed Proc       Date:  1974-08

7.  Enhancement of macrophage bactericidal capacity by antigenically stimulated immune lymphocytes.

Authors:  H B Simon; J N Sheagren
Journal:  Cell Immunol       Date:  1972-06       Impact factor: 4.868

8.  Bacterial precipitins in serum of patients with cystic fibrosis.

Authors:  M W Burns; J R May
Journal:  Lancet       Date:  1968-02-10       Impact factor: 79.321

9.  The enhancement of macrophage bacteriostasis by products of activated lymphocytes.

Authors:  R E Fowles; I M Fajardo; J L Leibowitch; J R David
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

10.  Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis.

Authors:  N Høiby; A Wiik
Journal:  Scand J Respir Dis       Date:  1975-05
View more
  22 in total

1.  Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Authors:  T K Kondratieva; N V Kobets; S V Khaidukov; V V Yeremeev; I V Lyadova; A S Apt; M F Tam; M M Stevenson
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Lymphocytes in cystic fibrosis lung disease: a tale of two immunities.

Authors:  R B Moss
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

3.  Mapping of the T-cell recognition sites of Pseudomonas aeruginosa PAK polar pili.

Authors:  W Smart; P A Sastry; W Paranchych; B Singh
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

4.  Inactivation of human gamma interferon by Pseudomonas aeruginosa proteases: elastase augments the effects of alkaline protease despite the presence of alpha 2-macroglobulin.

Authors:  R T Horvat; M Clabaugh; C Duval-Jobe; M J Parmely
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

5.  Adoptive transfer of resistance to Pseudomonas aeruginosa infection by splenocytes and bone marrow cells from BALB/c mice immunized by Pseudomonas aeruginosa lectin preparations.

Authors:  D Avichezer; N Gilboa-Garber; M Mumcuoglu; S Slavin
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

Review 6.  Vaccines for Pseudomonas aeruginosa: a long and winding road.

Authors:  Gregory P Priebe; Joanna B Goldberg
Journal:  Expert Rev Vaccines       Date:  2014-02-27       Impact factor: 5.217

Review 7.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

8.  Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity.

Authors:  R T Horvat; M J Parmely
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

9.  Intact splenic function in cystic fibrosis.

Authors:  N J Barrios; M Kiernan; R Beckerman; S Davis
Journal:  J Natl Med Assoc       Date:  1994-04       Impact factor: 1.798

10.  Synthesis and secretion of cystic fibrosis ciliary dyskinesia substances by purified subpopulations of leukocytes.

Authors:  G B Wilson; V J Bahm
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.